ISSN: 1875-533X (Online)
ISSN: 0929-8673 (Print)

Volume 22, 38 Issues, 2015

Download PDF Flyer

Current Medicinal Chemistry

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 6th of 59 in Chemistry & Medicinal
  • 47th of 254 in Pharmacology & Pharmacy
  • 81st of 289 in Biochemistry & Molecular Biology

Submit Abstracts Online Submit Manuscripts Online

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.853
5 - Year: 4.115

Upcoming Articles (E-Pub Abstracts ahead of Print)

Derivatives of Procaspase-Activating Compound 1 (PAC-1) and Their Anticancer Activities

Howard S. Roth and Paul J Hergenrother.

View Abstract

Potential Role of Polyphenols in the Prevention of Cardiovascular Diseases: Molecular Bases

Juan Guillermo Gormaz, Nicolas Valls, Camilo Sotomayor, Thomas Turner and Ramón Rodrigo.

View Abstract

Neuroprotective Activities of Marine Natural Products from Marine Sponges

Mousa Alghazwi, Yen Qi Kan, Wei Zhang, Wei Ping Gai and Xiao-Xin Yan.

View Abstract

Wrap-and-Strip Technology of Protein–Polyelectrolyte Complex for Biomedical Application

Kentaro Shiraki, Takaaki Kurinomaru and Shunsuke Tomita.

View Abstract

Natural Endoperoxides as Drug Lead Compounds

Ming Bu, Burton B. Yang and Liming Hu.

View Abstract

Apoptosis-inducing Effects of Amaryllidaceae Alkaloids

Jerald J. Nair, Johannes van and Jaume Bastida.

View Abstract

Peptidyl Arginine Deiminases and Neurodegenerative Diseases

Rhonda Tu, Hanna M. Grover and Lakshmi P Kotra.

View Abstract

Leveraging NMR and X-ray Data of the Free Ligands to Build Better Drugs Targeting Angiotensin II Type 1 G-Protein Coupled Receptor

Tahsin F. Kellici, Dimitrios Ntountaniotis, Eftichia Kritsi, Maria Zervou, Panagiotis Zoumpoulakis, Constantinos Potamitis, Serdar Durdagi, Ramin Ekhteiari Salmas, Gizem Ergun, Ebru Gokdemir, Maria Halabalaki, Ioannis P. Gerothanassis, George Liapakis, Andreas Tzakos and Thomas Mavromoustakos.

View Abstract

Colchicine, Biologic Agents and More for the Treatment of Familial Mediterranean Fever. The Old, the New, and the Rare

Piero Portincasa.

View Abstract

Macrocyclic trichothecenes as antifungal and anticancer compounds

Maira Peres de Carvalho, Herbert Weich and Wolf-Rainer Abraham.

View Abstract

Phosphodiesterase 4 (PDE4) inhibitors in the treatment of COPD: Promising drug candidates and future directions

Naisargee Parikh and Asit K Chakraborti.

View Abstract

Vascular effects of flavonoids

Bruno Almeida Rezende, Aline Carvalho Pereira, Steyner F. Cortes and Virginia Soares Lemos.

View Abstract

Oxazolidinones as Anti-tubercular Agents: Discovery, Development and Future Perspectives

Pradeep S. Jadhavar, Maulikkumar D. Vaja, Tejas M. Dhameliya and Asit K Chakraborti.

View Abstract

Histone modifications as molecular targets in nasopharyngeal cancer

Sukanya Shyamasundar, S Thameem Dheen and Boon Huat Bay.

View Abstract

Targeting IL-17 and IL-23 in Immune Mediated Renal Disease

Joanna R. Ghali, Stephen R. Holdsworth and A Richard Kitching.

View Abstract

Nanomedicininal approach of getting across the brood-brain barrier with radiolabeled nanoparticles

D. Psimadas, T. Tsotakos, E. Fragogeorgi and G Loudos.

View Abstract

Update on SAR studies toward new COX-1 selective inhibitors

Paola Vitalea, Antonio Scilimati and Maria Grazia Perrone.

View Abstract

Superoxide anion radical: generation and detection in cellular and non-cellular systems

Renan Campos Chisté, Marisa Freitas, Adriana Zerlotti Mercadante and Eduarda Fernandes.

View Abstract

Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications

Seyed Khosrow Tayebati, Gabriella Marucci, Michela Buccioni and Francesco Amenta.

View Abstract

Current and Future Chemotherapy For Chagas Disease

L Gaspar, CB Moraes, LH Freitas-Junior, S Ferrari, L Costantino, MP Costi, RP Coron, TK Smith, JL Siqueira-Neto, JH McKerrow and A Cordeiro-da-Silva.

View Abstract

Medical Gains of Chondroitin Sulfate upon Fucosylation

Vitor H Pomin.

View Abstract

Engineering Nanomedicines to Overcome Multidrug Resistance in Cancer Therapy

Giovanni L. Berettab and Francesca Cavalieri.

View Abstract

A Review of Bisindolylmethane as an Important Scaffold for Drug Discovery

Syahrul Imran, Muhammad Taha and Nor Hadiani Ismail.

View Abstract

ROS1 Kinase Inhibitors for Molecular-Targeted Therapies

M.M. Al-Sanea, A.Z. Abdelazem, B.S. Park, K.H. Yoo, T. Sim, Y.J. Kwon and SH Lee.

View Abstract

Editorial: Is The Female Heart Exposed To Cardiovascular Disease?

Genovefa Kolovou, Niki Katsiki and Dimitri P Mikhailidis.

View Abstract

Current advances in DOPA and DOPA-peptidomimetics: chemistry, applications and biological activity.

Bruno Mattia Bizzarri, Luca Rotelli, Giorgia Botta and Raffaele Saladino.

View Abstract

Molecular and cellular pathways as treatment targets for biologic therapies in systemic sclerosis

Theodoros Dimitroulas, Dimitris Daoussis, A. Garyfallos, Petros P. Sfikakis and George D Kitas.

View Abstract

Oxidative stress and post-stroke depression: possible therapeutic role of polyphenols?

Seyed Fazel Nabavi, Olivia M. Dean, Alyna Turner, Antoni Sureda, Maria Daglia and Seyed Mohammad Nabavi.

View Abstract

Neuronanomedicine - (Part II)

Wei-Yi Ong and Eng-Ang Ling.

View Abstract

PARP1: a promising target for the development of PARP1-based candidates for anticancer intervention

Yongzhou Hu.

View Abstract

Title Body mass index, lipid metabolism and estrogens: their impact on coronary heart disease

Genovefa D. Kolovou, Vana Kolovou, Peggy M. Kostakou and Sophie Mavrogeni.

View Abstract

Tumor Antigen-Derived Peptides Delivery for Cancer Immunotherapy

Ma Wenxue.

View Abstract

Interaction of Crotamine and Protamine, Small Cationic Peptides, With The Retinal Spreading Depression

EmptyYN="Y" Fernandes de Lima V M, P Spencer and W Hanke.

View Abstract

Editorial: Current status and progress of radiopharmaceuticals for molecular imaging and targeted therapy

Junbo Zhang.

View Abstract

On the Physiological Role of Cytosolic 5’-Nucleotidase II (Cn-II): Pathological and Therapeutical Implications

Maria Grazia Tozzi, Rossana Pesi and Simone Allegrini.

View Abstract

The role of soluble 5`-nucleotidases in the conversion of nucleotide analogs. Metabolic and therapeutic aspects

Andrzej C Składanowski.

View Abstract

The Enzymology of Cytosolic Pyrimidine 5’-Nucleotidases: Functional Analysis and Physiopathological Implications

Giulio Magni, Adolfo Amici and Giuseppe Orsomando.

View Abstract

5'-Nucleotidases, Nucleosides and their Distribution in the Brain: Pathological and Therapeutic Implications

Zsolt Kovács, Árpád Dobolyi, Katalin A. Kékesi and Gábor Juhász.

View Abstract

Therapeutic Perspectives for CN-II in Cancer

Lars Petter Jordheim.

View Abstract

Enzymatic Properties and Physiological Roles of Cytosolic 5’-Nucleotidase II

Roichi Itoh.

View Abstract

Is The Expression Of Deoxynucleoside Kinases And 5´-Nucleotidases In Animal Tissues Related To The Biological Effects Of Nucleoside Analogs?

Staffan Eriksson.

View Abstract

Editorial “ Metabolic, pathological, and therapeutic perspectives intracellular 5’-nucleotidases”

Piero Luigi Ipata.

View Abstract


Related Journals

Related eBooks

Webmaster Contact: Copyright © 2015 Bentham Science